# Study SOLACE SEPSIS

> **NCT06634069** · PHASE2 · RECRUITING · sponsor: **University Hospital Pilsen** · enrollment: 40 (estimated)

## Conditions studied

- Septic Shock
- Intracranial Hypertension

## Interventions

- **DRUG:** Sodium Lactate
- **DRUG:** 3% NaCl

## Key facts

- **NCT ID:** NCT06634069
- **Lead sponsor:** University Hospital Pilsen
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-24
- **Primary completion:** 2027-10-31
- **Final completion:** 2027-10-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06634069

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06634069, "Study SOLACE SEPSIS". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06634069. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*